• 14931 Citations
  • 64 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1988 2019

Filter
Article
2019

A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872

Galanis, E., Anderson, S. K., Twohy, E. L., Carrero, X. W., Dixon, J. G., Tran, D. D., Jeyapalan, S. A., Anderson, D. M., Kaufmann, T. J., Feathers, R. W., Giannini, C., Buckner, J. C., Anastasiadis, P. Z. & Schiff, D., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Glioblastoma
Placebos
Neoplasms
Therapeutics
National Cancer Institute (U.S.)
Open Access
temozolomide
Glioblastoma
Survivors
Radiation
Recurrence
1 Citation (Scopus)

Management of low-grade glioma: A systematic review and meta-Analysis

Brown, T. J., Bota, D. A., Van Den Bent, M. J., Brown, P. D., Maher, E., Aregawi, D., Liau, L. M., Buckner, J. C., Weller, M., Berger, M. S. & Glantz, M., Jul 27 2019, In : Neuro-Oncology Practice. 6, 4, p. 249-258 10 p., npy034.

Research output: Contribution to journalArticle

Glioma
Meta-Analysis
Drug Therapy
Disease-Free Survival
Radiation

Neuro-oncology clinical debate: Pcv or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma

Ruff, M. W., Buckner, J. C., Johnson, D. R., Van Den Bent, M. J. & Geurts, M., Jan 30 2019, In : Neuro-Oncology Practice. 6, 1, p. 17-21 5 p.

Research output: Contribution to journalArticle

temozolomide
Oligodendroglioma
Medical Oncology
Lomustine
Radiation

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Jaeckle, K. A., Anderson, S. K., Twohy, E. L., Dixon, J. G., Giannini, C., Jenkins, R. B., Egorin, M. J., Sarkaria, J. N., Brown, P. D., Flynn, P. J., Schwerkoske, J., Buckner, J. C. & Galanis, E., Jul 1 2019, In : Journal of neuro-oncology. 143, 3, p. 573-581 9 p.

Research output: Contribution to journalArticle

Oligodendroglioma
Astrocytoma
Neoplasms
Therapeutics
Anticonvulsants

Primary neuroendocrine carcinoma of the brain

Reed, C. T., Duma, N., Halfdanarson, T. R. & Buckner, J. C., Sep 1 2019, In : BMJ case reports. 12, 9, e230582.

Research output: Contribution to journalArticle

Open Access
Neuroendocrine Carcinoma
Brain
Neoplasms
Brain Neoplasms
Ventriculoperitoneal Shunt
2018
40 Citations (Scopus)

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

Sarkaria, J. N., Hu, L. S., Parney, I. F., Pafundi, D. H., Brinkmann, D. H., Laack, N. N., Giannini, C., Burns, T., Kizilbash, S., Laramy, J. K., Swanson, K., Kaufmann, T. J., Brown, P. D., Agar, N. Y. R., Galanis, E., Buckner, J. C. & Elmquist, W. F., Jan 22 2018, In : Neuro-Oncology. 20, 2, p. 184-191 8 p.

Research output: Contribution to journalArticle

Glioblastoma
Blood-Brain Barrier
Pharmaceutical Preparations
Neoplasms
Brain
7 Citations (Scopus)

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572

Schiff, D., Jaeckle, K. A., Anderson, S. K., Galanis, E., Giannini, C., Buckner, J. C., Stella, P., Flynn, P. J., Erickson, B. J., Schwerkoske, J. F., Kaluza, V., Twohy, E., Dancey, J., Wright, J. & Sarkaria, J. N., Apr 1 2018, In : Cancer. 124, 7, p. 1455-1463 9 p.

Research output: Contribution to journalArticle

Glioblastoma
Vascular Endothelial Growth Factor A
Neoplasms
Maximum Tolerated Dose
temozolomide
6 Citations (Scopus)

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: Results of Alliance N0874/ABTC 02

Galanis, E., Keith Anderson, S., Miller, C. R., Sarkaria, J. N., Jaeckle, K., Buckner, J. C., Ligon, K. L., Ballman, K. V., Moore, D. F., Nebozhyn, M., Loboda, A., Schiff, D., Ahluwalia, M. S., Lee, E. Q., Gerstner, E. R., Lesser, G. J., Prados, M., Grossman, S. A., Cerhan, J. H., Giannini, C. & 1 others, Wen, P. Y., Mar 27 2018, In : Neuro-Oncology. 20, 4, p. 546-556 11 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Radiotherapy
Neutropenia
Disease-Free Survival
10 Citations (Scopus)

Spindle cell rhabdomyosarcoma of bone with FUS–TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype

Dashti, N. K., Wehrs, R. N., Thomas, B. C., Nair, A., Davila, J., Buckner, J. C., Martinez, A. P., Sukov, W. R., Halling, K. C., Howe, B. M. & Folpe, A. L., Sep 1 2018, In : Histopathology. 73, 3, p. 514-520 7 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Bone and Bones
Needle Biopsy
Mandible
Differential Diagnosis

The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: A study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD

Pacyna, J. E., Kim, S., Yost, K. J., Sedlacek, H., Petereit, D., Kaur, J. S., Rapkin, B., Grubb, R., Paskett, E., Chang, G. J., Sloan, J. A., Basch, E., Major, B., Novotny, P., Taylor, J., Buckner, J. C., Parsons, J. K., Morris, M. & Tilburt, J. C., Aug 6 2018, In : BMC Cancer. 18, 1, 788.

Research output: Contribution to journalArticle

Decision Support Techniques
Prostatic Neoplasms
Randomized Controlled Trials
Research
Population
2017
5 Citations (Scopus)
Germ Cell and Embryonal Neoplasms
Radiotherapy
Drug Therapy
Disease-Free Survival
Recurrence
183 Citations (Scopus)

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

Brown, P. D., Ballman, K. V., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Whitton, A. C., Greenspoon, J., Parney, I. F., Laack, N. N., Ashman, J. B., Bahary, J. P., Hadjipanayis, C. G., Urbanic, J. J., Barker, F. G., Farace, E., Khuntia, D., Giannini, C., Buckner, J. C., Galanis, E. & Roberge, D., Aug 1 2017, In : The Lancet Oncology. 18, 8, p. 1049-1060 12 p.

Research output: Contribution to journalArticle

Radiosurgery
Brain Diseases
Radiotherapy
Brain
Neoplasm Metastasis
27 Citations (Scopus)
Methylation
Methyltransferases
Tumors
Neural networks
Biomarkers
15 Citations (Scopus)

Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial

Churilla, T. M., Ballman, K. V., Brown, P. D., Twohy, E. L., Jaeckle, K., Farace, E., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Garces, Y. I., Barker, F. G., Deming, R., Dixon, J. G., Burri, S. H., Chung, C., Ménard, C., Stieber, V. W., Pollock, B. E., Galanis, E., Buckner, J. C. & 1 others, Asher, A. L., 2017, (Accepted/In press) In : International Journal of Radiation Oncology Biology Physics.

Research output: Contribution to journalArticle

Radiosurgery
metastasis
brain
radiation therapy
Radiotherapy
9 Citations (Scopus)

The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma

Youland, R. S., Kreofsky, C. R., Schomas, D. A., Brown, P. D., Buckner, J. C. & Laack, N. N., Aug 23 2017, (Accepted/In press) In : Journal of Neuro-Oncology. p. 1-9 9 p.

Research output: Contribution to journalArticle

Glioma
Disease-Free Survival
Radiotherapy
Observation
Drug Therapy
2016
363 Citations (Scopus)

Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases a randomized clinical trial

Brown, P. D., Jaeckle, K., Ballman, K. V., Farace, E., Cerhan, J. H., Keith Anderson, S., Carrero, X. W., Barker, F. G., Deming, R., Burri, S. H., Ménard, C., Chung, C., Stieber, V. W., Pollock, B. E., Galanis, E., Buckner, J. C. & Asher, A. L., Jul 26 2016, In : JAMA - Journal of the American Medical Association. 316, 4, p. 401-409 9 p.

Research output: Contribution to journalArticle

Radiosurgery
Cognition
Radiotherapy
Randomized Controlled Trials
Neoplasm Metastasis
53 Citations (Scopus)
Methyltransferases
Glioblastoma
Methylation
Biomarkers
ROC Curve
317 Citations (Scopus)

Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma

Buckner, J. C., Shaw, E. G., Pugh, S. L., Chakravarti, A., Gilbert, M. R., Barger, G. R., Coons, S., Ricci, P., Bullard, D., Brown, P. D., Stelzer, K., Brachman, D., Suh, J. H., Schultz, C. J., Bahary, J. P., Fisher, B. J., Kim, H., Murtha, A. D., Bell, E. H., Won, M. & 2 others, Mehta, M. P. & Curran, W. J., Apr 7 2016, In : New England Journal of Medicine. 374, 14, p. 1344-1355 12 p.

Research output: Contribution to journalArticle

Lomustine
Procarbazine
Vincristine
Glioma
Radiotherapy
9 Citations (Scopus)

Seizures in patients with primary brain tumors: what is their psychosocial impact?

Shin, J. Y., Kizilbash, S., Robinson, S., Uhm, J. H., Hammack, J. E., Lachance, D. H., Buckner, J. C. & Jatoi, A., Jun 1 2016, In : Journal of Neuro-Oncology. 128, 2, p. 285-291 7 p.

Research output: Contribution to journalArticle

Brain Neoplasms
Seizures
Frustration
Quality of Life
Child Care
2015
10 Citations (Scopus)

Adult patients with supratentorial pilocytic astrocytoma: Long-term follow-up of ospective multicenter clinical trial NCCTG-867251 (alliance)

Brown, P. D., Anderson, S. K., Carrero, X. W., O'Neill, B. P., Giannini, C., Galanis, E., Shah, S. A., Abrams, R. A., Curran, W. J., Buckner, J. C. & Shaw, E. G., Apr 19 2015, In : Neuro-Oncology Practice. 2, 4, p. 199-204 6 p., npv031.

Research output: Contribution to journalArticle

Astrocytoma
Multicenter Studies
Clinical Trials
Radiotherapy
Nervous System
49 Citations (Scopus)

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

Ma, D. J., Galanis, E., Anderson, S. K., Schiff, D., Kaufmann, T. J., Peller, P. J., Giannini, C., Brown, P. D., Uhm, J. H., McGraw, S., Jaeckle, K. A., Flynn, P. J., Ligon, K. L., Buckner, J. C. & Sarkaria, J. N., Sep 1 2015, In : Neuro-Oncology. 17, 9, p. 1261-1269 9 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Radiotherapy
Sirolimus
Phosphatidylinositol 3-Kinase
640 Citations (Scopus)

Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors

Eckel-Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M. L., Smirnov, I. V., Sarkar, G., Caron, A. A., Kollmeyer, T. M., Praska, C. E., Chada, A. R., Halder, C., Hansen, H. M., McCoy, L. S., Bracci, P. M., Marshall, R. & 16 others, Zheng, S., Reis, G. F., Pico, A. R., O'Neill, B. P., Buckner, J. C., Giannini, C., Huse, J. T., Perry, A., Tihan, T., Berger, M. S., Chang, S. M., Prados, M. D., Wiemels, J., Wiencke, J. K., Wrensch, M. R. & Jenkins, R. B., Jun 25 2015, In : New England Journal of Medicine. 372, 26, p. 2499-2508 10 p.

Research output: Contribution to journalArticle

Glioma
Mutation
Neoplasms
Survival
National Institutes of Health (U.S.)
69 Citations (Scopus)

Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy

Chen, K., Yang, D., Li, X., Sun, B., Song, F., Cao, W., Brat, D. J., Gao, Z., Li, H., Liang, H., Zhao, Y., Zheng, H., Li, M., Buckner, J. C., Patterson, S. D., Ye, X., Reinhard, C., Bhathena, A., Joshi, D., Mischel, P. S. & 12 others, Croce, C. M., Wang, Y. M., Raghavakaimal, S., Li, H., Lu, X., Pan, Y., Chang, H., Ba, S., Luo, L., Cavenee, W. K., Zhang, W. & Hao, X., Jan 27 2015, In : Proceedings of the National Academy of Sciences of the United States of America. 112, 4, p. 1107-1112 6 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Stomach
Adenocarcinoma
Mutation
Genome
12 Citations (Scopus)

Pragmatic study designs for older adults with cancer: Report from the U13 conference

Nipp, R. D., Yao, N., Lowenstein, L. M., Buckner, J. C., Parker, I. R., Gajra, A., Morrison, V. A., Dale, W. & Ballman, K. V., Nov 1 2015, (Accepted/In press) In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

Pragmatic Clinical Trials
Research Personnel
Clinical Trials
Neoplasms
Geriatrics
7 Citations (Scopus)

Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure

Berg, A. K., Buckner, J. C., Galanis, E., Jaeckle, K. A., Ames, M. M. & Reid, J. M., Nov 1 2015, In : Journal of Clinical Pharmacology. 55, 11, p. 1303-1312 10 p.

Research output: Contribution to journalArticle

irinotecan
Anticonvulsants
Pharmacokinetics
Enzymes
Glioma
12 Citations (Scopus)
Radiation Oncology
Glioma
Lomustine
Procarbazine
Radiotherapy

Success, significance, and social responsibility

Buckner, J. C., May 1 2015, In : Neuro-Oncology. 17, 5, p. 629-630 2 p.

Research output: Contribution to journalArticle

Social Responsibility
Glioblastoma
3 Citations (Scopus)
temozolomide
Alkylating Antineoplastic Agents
Dacarbazine
Aplastic Anemia
Astrocytoma
9 Citations (Scopus)

Template for reporting results of biomarker testing of specimens from patients with tumors of the central nervous system

Members of the Cancer Biomarker Reporting Committee, College of American Pathologists, Sep 1 2015, In : Archives of Pathology and Laboratory Medicine. 139, 9, p. 1087-1093 7 p.

Research output: Contribution to journalArticle

DNA Mutational Analysis
Central Nervous System Neoplasms
Hospital Laboratories
Germ Cell and Embryonal Neoplasms
Tumor Biomarkers
11 Citations (Scopus)
Magnetic resonance
Glioblastoma
Software packages
Blood
Software
2014
219 Citations (Scopus)

Benefit from procarbazine, lomustine and vincristine in oligodendroglial tumors is associated with mutation of IDH

Cairncross, J. G., Wang, M., Jenkins, R. B., Shaw, E. G., Giannini, C., Brachman, D. G., Buckner, J. C., Fink, K. L., Souhami, L., Laperriere, N. J., Huse, J. T., Mehta, M. P. & Curran, W. J., Mar 10 2014, In : Journal of Clinical Oncology. 32, 8, p. 783-790 8 p.

Research output: Contribution to journalArticle

Lomustine
Procarbazine
Vincristine
Chemoradiotherapy
Mutation
5 Citations (Scopus)

Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor

Lester, R. A., Brown, L. C., Eckel, L. J., Foote, R. T., NageswaraRao, A. A., Buckner, J. C., Parney, I. F., Wetjen, N. M. & Laack, N. N., Oct 22 2014, In : Journal of Neuro-Oncology. 120, 2, p. 371-379 9 p.

Research output: Contribution to journalArticle

Primitive Neuroectodermal Tumors
Central Nervous System
Disease-Free Survival
Survival
Pediatrics
56 Citations (Scopus)

Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: Secondary analysis of RTOG 98-02

Prabhu, R. S., Won, M., Shaw, E. G., Hu, C., Brachman, D. G., Buckner, J. C., Stelzer, K. J., Barger, G. R., Brown, P. D., Gilbert, M. R. & Mehta, M. P., Feb 20 2014, In : Journal of Clinical Oncology. 32, 6, p. 535-541 7 p.

Research output: Contribution to journalArticle

Glioma
Cognition
Radiotherapy
Drug Therapy
Disease-Free Survival
17 Citations (Scopus)

Impact of imaging measurements on response assessment in glioblastoma clinical trials

Reardon, D. A., Ballman, K. V., Buckner, J. C., Chang, S. M. & Ellingson, B. M., Oct 1 2014, In : Neuro-Oncology. 16, p. vii24-vii35

Research output: Contribution to journalArticle

Glioblastoma
Clinical Trials
Technology
Diffusion Magnetic Resonance Imaging
Perfusion Imaging
10 Citations (Scopus)

Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma

Call, J. A., Naik, M., Rodriguez, F. J., Giannini, C., Wu, W., Buckner, J. C., Parney, I. F. & Laack, N. N., Feb 2014, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 37, 1, p. 1-7 7 p.

Research output: Contribution to journalArticle

Medulloblastoma
Disease-Free Survival
Drug Therapy
Survival
Histology
33 Citations (Scopus)

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

Singh, J. A., Satele, D., Pattabasavaiah, S., Buckner, J. C. & Sloan, J. A., Dec 18 2014, In : Health and Quality of Life Outcomes. 12, 1, 187.

Research output: Contribution to journalArticle

Quality of Life
Hospices
Neoplasms
Caregivers
Healthy Volunteers
13 Citations (Scopus)
Pain Measurement
Fatigue
Symptom Assessment
Quality of Life
Physicians
30 Citations (Scopus)

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)

Wen, P. Y., Cloughesy, T. F., Ellingson, B. M., Reardon, D. A., Fine, H. A., Abrey, L., Ballman, K., Bendszuz, M., Buckner, J. C., Chang, S. M., Prados, M. D., Pope, W. B., Gregory Sorensen, A., van den Bent, M. & Yung, W. K. A. L., Oct 1 2014, In : Neuro-Oncology. 16, p. vii36-vii47

Research output: Contribution to journalArticle

Neuroimaging
Brain Neoplasms
Clinical Trials
Education
Pharmaceutical Preparations
21 Citations (Scopus)

The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma

Kizilbash, S., Giannini, C., Voss, J. S., Decker, P. A., Jenkins, R. B., Hardie, J., Laack, N. N., Parney, I. F., Uhm, J. H. & Buckner, J. C., Sep 27 2014, In : Journal of Neuro-Oncology. 120, 1, p. 85-93 9 p.

Research output: Contribution to journalArticle

temozolomide
Isocitrate Dehydrogenase
Astrocytoma
Radiation
Mutation
2013
36 Citations (Scopus)

Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years

Youland, R. S., Schomas, D. A., Brown, P. D., Nwachukwu, C., Buckner, J. C., Giannini, C., Parney, I. F. & Laack, N. N., Aug 2013, In : Neuro-Oncology. 15, 8, p. 1102-1110 9 p.

Research output: Contribution to journalArticle

Glioma
Disease-Free Survival
Histology
Radiotherapy
Survival
34 Citations (Scopus)

Gliomatosis cerebri: Clinical characteristics, management, and outcomes

Chen, S., Tanaka, S., Giannini, C., Morris, J., Yan, E. S., Buckner, J. C., Lachance, D. H. & Parney, I. F., Apr 2013, In : Journal of Neuro-Oncology. 112, 2, p. 267-275 9 p.

Research output: Contribution to journalArticle

Neuroepithelial Neoplasms
Survival
Radiotherapy
Neoplastic Processes
Drug Therapy
16 Citations (Scopus)

Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials

Abrams, J. S., Mooney, M. M., Zwiebel, J. A., Korn, E. L., Friedman, S. H., Finnigan, S. R., Schettino, P. R., Denicoff, A. M., Kruhm, M. G., Montello, M., Misra, R. R., Ansher, S. S., Dipiazza, K. J., Souhan, E. M., Wickerham, D. L., Giantonio, B. J., O'Donnell, R. T., Sullivan, D. M., Soto, N. I., Fleming, G. F. & 11 others, Prindiville, S. A., Petryshyn, R. A., Hautala, J. A., Grad, O., Zuckerman, B. L., Meyer, R. M., Yao, J. C., Baker, L. A., Buckner, J. C., Hortobagyi, G. N. & Doroshow, J. H., Jul 3 2013, In : Journal of the National Cancer Institute. 105, 13, p. 954-959 6 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Clinical Trials
Research Personnel
TimeLine
Research
47 Citations (Scopus)

New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: A pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials

Gorlia, M. T., Wu, W., Wang, M., Baumert, B. G., Mehta, M., Buckner, J. C., Shaw, E., Brown, P., Stupp, R., Galanis, E., Lacombe, D. & Van Den Bent, M. J., 2013, In : Neuro-Oncology. 15, 11, p. 1568-1579 12 p.

Research output: Contribution to journalArticle

Phase III Clinical Trials
Glioma
Pathology
Survival
Disease-Free Survival
541 Citations (Scopus)

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: Long-term results of RTOG 9402

Cairncross, G., Wang, M., Shaw, E., Jenkins, R. B., Brachman, D., Buckner, J. C., Fink, K., Souhami, L., Laperriere, N., Curran, W. & Mehta, M., Jan 20 2013, In : Journal of Clinical Oncology. 31, 3, p. 337-343 7 p.

Research output: Contribution to journalArticle

Oligodendroglioma
Chemoradiotherapy
Lomustine
Procarbazine
Radiotherapy
75 Citations (Scopus)

Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): A North Central Cancer Treatment Group Trial

Galanis, E., Anderson, S. K., Lafky, J. M., Uhm, J. H., Giannini, C., Kumar, S. K., Kimlinger, T. K., Northfelt, D. W., Flynn, P. J., Jaeckle, K. A., Kaufmann, T. J. & Buckner, J. C., Sep 1 2013, In : Clinical Cancer Research. 19, 17, p. 4816-4823 8 p.

Research output: Contribution to journalArticle

Glioblastoma
Vascular Endothelial Growth Factor A
Neoplasms
Single Nucleotide Polymorphism
Biomarkers
57 Citations (Scopus)

Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients

Tanaka, S., Meyer, F. B., Buckner, J. C., Uhm, J. H., Yan, E. S. & Parney, I. F., Apr 2013, In : Journal of Neurosurgery. 118, 4, p. 786-798 13 p.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Odds Ratio
Disease-Free Survival
Biopsy
2012
83 Citations (Scopus)

A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation

Jenkins, R. B., Xiao, Y., Sicotte, H., Decker, P. A., Kollmeyer, T. M., Hansen, H. M., Kosel, M. L., Zheng, S., Walsh, K. M., Rice, T., Bracci, P., McCoy, L. S., Smirnov, I., Patoka, J. S., Hsuang, G., Wiemels, J. L., Tihan, T., Pico, A. R., Prados, M. D., Chang, S. M. & 13 others, Berger, M. S., Caron, A. A., Fink, S. R., Halder, C., Rynearson, A. L., Fridley, B. L., Buckner, J. C., O'Neill, B. P., Giannini, C., Lachance, D. H., Wiencke, J. K., Eckel-Passow, J. E. & Wrensch, M. R., Oct 2012, In : Nature Genetics. 44, 10, p. 1122-1125 4 p.

Research output: Contribution to journalArticle

Astrocytoma
Single Nucleotide Polymorphism
Mutation
Glioma
Neoplasms
62 Citations (Scopus)

Conditional probability of long-term survival in glioblastoma: A population-based analysis

Johnson, D. R., Ma, D. J., Buckner, J. C. & Hammack, J. E., Nov 15 2012, In : Cancer. 118, 22, p. 5608-5613 6 p.

Research output: Contribution to journalArticle

Glioblastoma
Survival
Population
Survivors
Epidemiology

Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers

Bible, K. C., Smallridge, R. C., Morris, J. C., Molina, J. R., Suman, V. J., Copland, J. A. III., Rubin, J., Menefee, M. E., Sideras, K., Maples, W. J., McIver, B., Fatourechi, V., Hay, I. D., Foote, R. L., Garces, Y. I., Kasperbauer, J., Thompson, G. B., Grant, C. S., Richards, M. L., Sebo, T. & 9 others, Lloyd, R., Eberhardt, N. L., Reddi, H. V., Casler, J. D., Karlin, N. J., Westphal, S. A., Richardson, R. L., Buckner, J. C. & Erlichman, C., May 2012, In : American Journal of Managed Care. 18, 5

Research output: Contribution to journalArticle

Endocrine Gland Neoplasms
Neoplasms
Medical Oncology
Clinical Trials
Endocrine System Diseases